OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin Contracts

Key Takeaways OPK posted Q4 loss of 4 cents, beating estimates as $148.5M revenue topped estimates despite 19% drop.OPK's Diagnostics revenue fell 30.5% on lower test volume after BioReference asset sale.OPK guides 2026 revenues of $530M-$560M, with Q1 outlook of $125M-$140M.OPKO Health, Inc. (OPK) delivered a loss per share of 4 cents in the fourth quarter of 2025, against an earnings per share of a cent in the prior-year quarter. Earnings beat the Zacks Consensus Estimate of a loss of 7 cents per share by ...